XOMAP Q2 2020 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$444,000-53.8% YoY

Gross Profit

$406,00091.4% margin

Operating Income

-$3M-709.7% margin

Net Income

-$4M-795.7% margin

EPS (Diluted)

$-0.31

QoQ Revenue Growth

-44.8%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$773,000

Balance Sheet

Total Assets

$88M

Total Liabilities

$49M

Stockholders' Equity

$38M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$444,000	$962,000	-53.8%
Gross Profit	$406,000	$238,000	+70.6%
Operating Income	-$3M	-$5M	+33.1%
Net Income	-$4M	-$4M	+13.2%